By Lana Pine | Published on January 23, 2025 4 min read A study of more than 350,000 patients and found that, overall, patients who were treated with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) did not have a significantly higher risk of thyroid cancer
Eyvazi S, Farajnia S, Dastmalchi S, Kanipour F, Zarredar H, Bandehpour M
To prevent or recover from deficiencies or disease, how should we decide what foods to focus on for optimal health
Gratis verzending bij bestellingen vanaf 250
Knowing the half-life is one thing, but knowing when the medication is truly gone is another
Both positive and negative mental health impacts have been reported from patients taking GLP-1s